ACCESS Newswire

ITOCO Inc.

27.7.2021 16:17:09 CEST | ACCESS Newswire | Press release

Share
ITOCO Welcomes Mr. Rene A. Ibarra to its Technical Management Team, Carbon Credits

TORONTO, ON / ACCESSWIRE / July 27, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to announce that Mr. Rene Ibarra has joined the firm's Technical Management Team, Carbon Credits and Capture.

Previously, he has been accredited as a leading verifier by the Climate Action Reserve to verify Carbon Capture projects under the standard of the Mexico Forest Protocol since 2016, participating in the evaluation of 48 projects developed in the State of Mexico, Mexico City, Puebla, Oaxaca, Veracruz, Hidalgo and Durango under the Mexico Forest Protocol. He also participated in national and international forums such as the North American Carbon World conference in its editions from 2017 to 2019, the year in which he was the recipient of the CARROT award granted by the Climate Action Reserve to its most outstanding partners and collaborators for promoting and encouraging the establishment of forest Carbon sequestration projects in Mexico.

Additionally, he worked as Coordinator of Forest Communities for WRI Mexico's CO2munitario project; coordinating the implementation of projects at the national level and contributing its experience in the training of personnel in site and in the integration of evidence of compliance with social and environmental safeguards, distribution of benefits, calculation of removals and the eligibility and additional criteria of the Mexico Forest Protocol.

Mr. Ibarra also worked as a Specialist in Certification of National and International Standards focused on the sustainable management of natural resources, in the Association of Normalization and Certification A.C.

Further, he served as a Certification Engineer for the evaluation of the NMX-AA-143-SCFI-2015 for the sustainable management of forest resources; standard in which he led the works of certification of 156 forest properties in 13 states of the republic, managing to certify 914, 720 hectares until 2019. He was also a leading verifier in the NMX-AA-170-SCFI-2016 for the certification of forest nurseries; NMX-AA-169-SCFI-2016 for the establishment of production units and forest germplasm management and as Substitute Technical Manager of the Verification Unit, accredited by the Mexican accreditation entity for the evaluation of the NMX-AA-144- standards. SCFI-2008 and NMX-N-107-SCFI-2010 related to the sustainable production and free of elemental chlorine of paper.

Mr. Ibarra is a key addition to the existing team currently updating various agreements to amalgamate Nopal Cactus Farms and related assets in Mexico and elsewhere for the purpose of creating commercial products including foods, renewable bio-energy products, and Carbon Credits.

The Nopal cactus has unique and significant Carbon reducing properties which will be discussed in upcoming releases.

Please see www.itoco.net for further information.

About ITOCO Inc.

ITOCO's mission is to be a global leader in developing, distributing, and producing Bio Tech related technologies and methodologies in a compliant environmentally friendly manner. ITOCO Inc. trades on the OTC Markets, symbol: ITMC. ITOCO is a 14-year-old publicly quoted specialty Bio Tech development, production and distribution company based in Toronto, Canada and Nevada USA. Itoco seeks to partner with outstanding individuals and companies within this field to joint venture, research, and co-develop Bio Tech related products and technologies to the market.

www.itoco.net

Forward-Looking Statements

This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, potential, intends, plans, hopes, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.

CONTACT:

Michael Paul, C.E.T.
President & CEO
ITOCO INC
ir@itoco.net
+1-905-829-5000
www.itoco.net

SOURCE: ITOCO Inc.



View source version on accesswire.com:
https://www.accesswire.com/657224/ITOCO-Welcomes-Mr-Rene-A-Ibarra-to-its-Technical-Management-Team-Carbon-Credits

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis30.9.2026 19:00:00 CEST | Press release

PRINCETON, NJ / ACCESS Newswire / September 30, 2026 / PharmaNest, Inc. an AI-enabled digital pathology company specializing in the quantitative and spatial characterization of fibrosis and Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced a collaboration to integrate advanced digital pathology into Mediar's ongoing EncompaSSc Phase 2 clinical trial of MTX-474 in patients with diffuse cutaneous systemic sclerosis (dcSSc). MTX-474 is a first-in-class human IgG1 monoclonal antibody designed to neutralize EphrinB2 signaling, a pathway implicated in myofibroblast activation, extracellular matrix (ECM) deposition and tissue remodeling known to drive fibrosis in SSc. The randomized, double-blind, placebo-controlled EncompaSSc Phase 2 study is evaluating the safety and efficacy of MTX-474 in patients with dcSSc. Under the collaboration, PharmaNest will apply its FibroNest™ AI-enabled digital path

Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans30.9.2026 15:50:00 CEST | Press release

NEW YORK, NY / ACCESS Newswire / September 30, 2026 / Innodata Inc. (Nasdaq:INOD) today announced the opening of a new R&D laboratory that is designed to generate the data needed to train the next generation of human-like robots and independently validate the performance data that robots generate internally. Innodata developed the lab in collaboration with Vicon, a leader in motion capture who consulted on the lab design and continues to provide technical consulting. The New Jersey-based lab is equipped with high-precision, low-latency infrared optical tracking cameras that measure movement down to the sub-millimeter level-a degree of accuracy that methods such as wearable inertial measurement unit (IMU) sensors and single-camera (monocular) video analysis typically cannot match. The lab addresses an urgent need for high-quality training data for humanoids, industrial robots, and other forms of physical AI. While many other data providers infer 3D motion by analyzing 2D video, Innodata

Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 202630.9.2026 00:45:00 CEST | Press release

THUNDER BAY, ON / ACCESS Newswire / September 29, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU)(OTC PINK:CLRMF) announces that it has filed its unaudited consolidated interim financial statements and management's discussion and analysis for the six-month period ended July 31, 2026, available for viewing on www.sedarplus.ca. Financial HighlightsTotal assets as at July 31, 2026 of $35,465,204Total cash as at July 31, 2026 of $422,500Working capital deficiency as at July 31, 2026 of $3,188,114Shareholder's equity as at July 31, 2026 of $31,803,864 During the six-month period ended July 31, 2026, the Company incurred $164,309 in cost for exploration activities at the Thunder Bay North project. During the second fiscal quarter, the Company focused on finalizing the proposed amalgamation while continuing discussions on Advanced Exploration permitting and re-assessment of past geophysical work to highlight areas of focus for drilling and geophysics in

Continent 8 and FuturePath AI Launch Future8: Accountable AI for Regulated Industries29.9.2026 15:00:00 CEST | Press release

LISBON, PT / ACCESS Newswire / September 29, 2026 / Continent 8 Technologies and FuturePath AI today launched Future8, an AI-native operating company built for regulated operators, formed as a joint venture between the two companies. Announced at SBC Summit Lisbon, Future8 combines FuturePath's enterprise AI applications platform with Continent 8's licensed global operating footprint, enabling the iGaming industry to deploy auditable AI without compromising compliance, data sovereignty and operational control. Built for highly regulated environments, Future8 enables operators to move from AI experimentation to production deployment by embedding governance, approvals and auditability into every workflow from day one. Continent 8 brings licensed data centers and a private global network spanning more than 100 locations, built over 28 years serving the biggest iGaming and online brands, along with AI-enabled Global Capability Centers in India, the Philippines and Bulgaria. The company als

Europe SPAC Summit 2026 Invites European Private Companies to Explore the SPAC Path to U.S. Public Markets29.9.2026 15:00:00 CEST | Press release

NEW YORK, NY AND ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2026 / A growing number of European companies in frontier technologies, critical minerals, advanced manufacturing, defense tech, energy, and consumer sectors are evaluating a merger with a special purpose acquisition company (SPAC) as a faster route to a U.S. listing, a valuation that reflects global investor demand, and access to follow-on capital. The Europe SPAC Summit 2026 (ESPAC'26), co-hosted by AUM Advisors and MBP Global, is inviting the CEOs, CFOs, founders, and board members of late-stage European private companies to The Dolder Grand in Zurich on Thursday, December 10, 2026, to learn how the process works and to meet the investment bankers, institutional investors, and SPAC sponsors who make these transactions happen. Attendance is by invitation only and free of charge for qualified companies. Europe's recent de-SPACs show what is possible. Kyivstar, Ukraine's largest mobile operator, listed on Nasdaq thr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye